{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:08:28Z","timestamp":1790017708745,"version":"4.0.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173280"],"award-info":[{"award-number":["82173280"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2025ZNSFSC0559"],"award-info":[{"award-number":["2025ZNSFSC0559"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["2023SCUH0071"],"award-info":[{"award-number":["2023SCUH0071"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2025,6,18]]},"DOI":"10.1038\/s41416-025-02992-9","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T16:16:43Z","timestamp":1744388203000},"page":"997-1009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Repurposing chlorpromazine for the treatment of triple-negative breast cancer growth and metastasis based on modulation of mitochondria-mediated apoptosis and autophagy\/mitophagy"],"prefix":"10.1038","volume":"132","author":[{"given":"Yamin","family":"Pu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4024-4881","authenticated-orcid":false,"given":"Yiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7939-9995","authenticated-orcid":false,"given":"Yong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"2992_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"2992_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2147\/OTT.S67673","volume":"8","author":"F Tomao","year":"2015","unstructured":"Tomao F, Papa A, Zaccarelli E, Rossi L, Caruso D, Minozzi M, et al. Triple-negative breast cancer: new perspectives for targeted therapies. Onco Targets Ther. 2015;8:177\u201393.","journal-title":"Onco Targets Ther"},{"key":"2992_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41591-020-01195-4","volume":"27","author":"K Ganesh","year":"2021","unstructured":"Ganesh K, Massagu\u00e9 J. Targeting metastatic cancer. Nat Med. 2021;27:34\u201344.","journal-title":"Nat Med"},{"key":"2992_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-981-32-9620-6_9","volume":"1187","author":"MY Kim","year":"2021","unstructured":"Kim MY. Breast cancer metastasis. Adv Exp Med Biol. 2021;1187:183\u2013204.","journal-title":"Adv Exp Med Biol"},{"key":"2992_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1046-3","volume":"9","author":"Z Feng","year":"2018","unstructured":"Feng Z, Xia Y, Gao T, Xu F, Lei Q, Peng C, et al. The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0\/G1 arrest and apoptosis. Cell Death Dis. 2018;9:1006.","journal-title":"Cell Death Dis"},{"key":"2992_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41416-020-01175-y","volume":"124","author":"C Bailleux","year":"2021","unstructured":"Bailleux C, Eberst L, Bachelot T. Treatment strategies for breast cancer brain metastases. Br J Cancer. 2021;124:142\u201355.","journal-title":"Br J Cancer"},{"key":"2992_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203884","volume":"10","author":"W Liu","year":"2023","unstructured":"Liu W, Zheng M, Zhang R, Jiang Q, Du G, Wu Y, et al. RNF126-Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple-Negative Breast Cancer to Radiotherapy. Adv Sci. 2023;10:e2203884.","journal-title":"Adv Sci"},{"key":"2992_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/tbj.13230","volume":"25","author":"P Gabani","year":"2019","unstructured":"Gabani P, Weiner AA, Hernandez-Aya LF, Khwaja S, Roach MC, Ochoa LL, et al. Treatment response as predictor for brain metastasis in triple negative breast cancer: a score-based model. Breast J. 2019;25:363\u201372.","journal-title":"Breast J"},{"key":"2992_CR9","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202216033","volume":"15","author":"R Dinami","year":"2023","unstructured":"Dinami R, Pompili L, Petti E, Porru M, D\u2019Angelo C, Di Vito S, et al. MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative breast cancer. EMBO Mol Med. 2023;15:e16033.","journal-title":"EMBO Mol Med"},{"key":"2992_CR10","first-page":"474","volume":"27","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Li C, Zhang Y, Li C, Chu Y, Li X, et al. Nanomaterials with dual immunomodulatory functions for synergistic therapy of breast cancer brain metastases. Bioact Mater. 2023;27:474\u201387.","journal-title":"Bioact Mater"},{"key":"2992_CR11","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/neuonc\/noy044","volume":"20","author":"R Pedrosa","year":"2018","unstructured":"Pedrosa R, Mustafa DA, Soffietti R, Kros JM. Breast cancer brain metastasis: molecular mechanisms and directions for treatment. Neuro Oncol. 2018;20:1439\u201349.","journal-title":"Neuro Oncol"},{"key":"2992_CR12","first-page":"392","volume":"6","author":"J Fares","year":"2019","unstructured":"Fares J, Kanojia D, Cordero A, Rashidi A, Miska J, Schwartz CW, et al. Current state of clinical trials in breast cancer brain metastases. Neurooncol Pr. 2019;6:392\u2013401.","journal-title":"Neurooncol Pr"},{"key":"2992_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05345-z","volume":"13","author":"Q Li","year":"2022","unstructured":"Li Q, Chu Y, Li S, Yu L, Deng H, Liao C, et al. The oncoprotein MUC1 facilitates breast cancer progression by promoting Pink1-dependent mitophagy via ATAD3A destabilization. Cell Death Dis. 2022;13:899.","journal-title":"Cell Death Dis"},{"key":"2992_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/cdd.2012.81","volume":"20","author":"G Ashrafi","year":"2013","unstructured":"Ashrafi G, Schwarz TL. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ. 2013;20:31\u201342.","journal-title":"Cell Death Differ"},{"key":"2992_CR15","doi-asserted-by":"publisher","first-page":"736","DOI":"10.7150\/thno.79876","volume":"13","author":"Y Lu","year":"2023","unstructured":"Lu Y, Li Z, Zhang S, Zhang T, Liu Y, Zhang L. Cellular mitophagy: Mechanism, roles in diseases and small molecule pharmacological regulation. Theranostics. 2023;13:736\u201366.","journal-title":"Theranostics"},{"key":"2992_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12929-018-0487-4","volume":"25","author":"R Guan","year":"2018","unstructured":"Guan R, Zou W, Dai X, Yu X, Liu H, Chen Q, et al. Mitophagy, a potential therapeutic target for stroke. J Biomed Sci. 2018;25:87.","journal-title":"J Biomed Sci"},{"key":"2992_CR17","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1080\/15548627.2022.2139080","volume":"19","author":"R Han","year":"2023","unstructured":"Han R, Liu Y, Li S, Li XJ, Yang W. PINK1-PRKN mediated mitophagy: differences between in vitro and in vivo models. Autophagy. 2023;19:1396\u2013405.","journal-title":"Autophagy"},{"key":"2992_CR18","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1080\/15548627.2023.2182482","volume":"19","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zhang H, Liu Y, Zhang S, Su P, Wang L, et al. Hypoxia-induced GPCPD1 depalmitoylation triggers mitophagy via regulating PRKN-mediated ubiquitination of VDAC1. Autophagy. 2023;19:2443\u201363.","journal-title":"Autophagy"},{"key":"2992_CR19","doi-asserted-by":"crossref","unstructured":"Zheng B, Wang Y, Zhou B, Qian F, Liu D, Ye D, et al. Urolithin A inhibits breast cancer progression via activating TFEB-mediated mitophagy in tumor macrophages. J Adv Res. 2025;69:125\u20138.","DOI":"10.1016\/j.jare.2024.04.010"},{"key":"2992_CR20","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1111\/jcmm.17917","volume":"27","author":"J Fang","year":"2023","unstructured":"Fang J, Zou X, Gong L, Xi J, Liu Y, Yang X, et al. Acid ground nano-realgar processed product inhibits breast cancer by inducing mitophagy via the p53\/BNIP3\/NIX pathway. J Cell Mol Med. 2023;27:3478\u201390.","journal-title":"J Cell Mol Med"},{"key":"2992_CR21","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.1016\/j.apsb.2023.05.019","volume":"13","author":"C Xiao","year":"2023","unstructured":"Xiao C, Sun Y, Fan J, Nguyen W, Chen S, Long Y, et al. Engineering cannabidiol synergistic carbon monoxide nanocomplexes to enhance cancer therapy via excessive autophagy. Acta Pharm Sin B. 2023;13:4591\u2013606.","journal-title":"Acta Pharm Sin B"},{"key":"2992_CR22","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41582-020-0397-4","volume":"16","author":"C Ballard","year":"2020","unstructured":"Ballard C, Aarsland D, Cummings J, O\u2019Brien J, Mills R, Molinuevo JL, et al. Drug repositioning and repurposing for Alzheimer disease. Nat Rev Neurol. 2020;16:661\u201373.","journal-title":"Nat Rev Neurol"},{"key":"2992_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.mehy.2012.03.026","volume":"79","author":"G Fond","year":"2012","unstructured":"Fond G, Macgregor A, Attal J, Larue A, Brittner M, Ducasse D, et al. Antipsychotic drugs: pro-cancer or anti-cancer? A systematic review. Med Hypotheses. 2012;79:38\u201342.","journal-title":"Med Hypotheses"},{"key":"2992_CR24","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.apsb.2021.09.007","volume":"12","author":"C Zheng","year":"2022","unstructured":"Zheng C, Yu X, Liang Y, Zhu Y, He Y, Liao L, et al. Targeting PFKL with penfluridol inhibits glycolysis and suppresses esophageal cancer tumorigenesis in an AMPK\/FOXO3a\/BIM-dependent manner. Acta Pharm Sin B. 2022;12:1271\u201387.","journal-title":"Acta Pharm Sin B"},{"key":"2992_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1785-9","volume":"10","author":"WY Hung","year":"2019","unstructured":"Hung WY, Chang JH, Cheng Y, Cheng GZ, Huang HC, Hsiao M, et al. Autophagosome accumulation-mediated ATP energy deprivation induced by penfluridol triggers nonapoptotic cell death of lung cancer via activating unfolded protein response. Cell Death Dis. 2019;10:538.","journal-title":"Cell Death Dis"},{"key":"2992_CR26","doi-asserted-by":"crossref","unstructured":"Huang C, Lan W, Fraunhoffer N, Meilerman A, Iovanna J, Santofimia-Casta\u00f1o P dissecting the anticancer mechanism of trifluoperazine on pancreatic ductal adenocarcinoma. Cancers. 2019;11:1869.","DOI":"10.3390\/cancers11121869"},{"key":"2992_CR27","doi-asserted-by":"publisher","first-page":"5464","DOI":"10.1158\/0008-5472.CAN-21-0162","volume":"81","author":"C Faure","year":"2021","unstructured":"Faure C, Djerbi-Bouilli\u00e9 R, Domingot A, Bouzinba-Segard H, Taouji S, Saidi Y, et al. Allosteric Inhibition of HER2 by moesin-mimicking compounds targets HER2-Positive cancers and brain metastases. Cancer Res. 2021;81:5464\u201376.","journal-title":"Cancer Res"},{"key":"2992_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-020-0871-6","volume":"22","author":"RJ Wickham","year":"2020","unstructured":"Wickham RJ. Nausea and vomiting: a palliative care imperative. Curr Oncol Rep. 2020;22:1.","journal-title":"Curr Oncol Rep"},{"key":"2992_CR29","doi-asserted-by":"publisher","first-page":"27580","DOI":"10.18632\/oncotarget.4768","volume":"6","author":"WY Lee","year":"2015","unstructured":"Lee WY, Lee WT, Cheng CH, Chen KC, Chou CM, Chung CH, et al. Repositioning antipsychotic chlorpromazine for treating colorectal cancer by inhibiting sirtuin 1. Oncotarget. 2015;6:27580\u201395.","journal-title":"Oncotarget"},{"key":"2992_CR30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3858\/emm.2010.42.5.041","volume":"42","author":"SY Shin","year":"2010","unstructured":"Shin SY, Kim CG, Kim SH, Kim YS, Lim Y, Lee YH. Chlorpromazine activates p21Waf1\/Cip1 gene transcription via early growth response-1 (Egr-1) in C6 glioma cells. Exp Mol Med. 2010;42:395\u2013405.","journal-title":"Exp Mol Med"},{"key":"2992_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.cbi.2019.01.033","volume":"302","author":"CE Yang","year":"2019","unstructured":"Yang CE, Lee WY, Cheng HW, Chung CH, Mi FL, Lin CW. The antipsychotic chlorpromazine suppresses YAP signaling, stemness properties, and drug resistance in breast cancer cells. Chem Biol Interact. 2019;302:28\u201335.","journal-title":"Chem Biol Interact"},{"key":"2992_CR32","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.18632\/oncotarget.28010","volume":"12","author":"P Kamgar-Dayhoff","year":"2021","unstructured":"Kamgar-Dayhoff P, Brelidze TI. Multifaceted effect of chlorpromazine in cancer: implications for cancer treatment. Oncotarget. 2021;12:1406\u201326.","journal-title":"Oncotarget"},{"key":"2992_CR33","first-page":"459","volume":"9","author":"F Xu","year":"2019","unstructured":"Xu F, Xia Y, Feng Z, Lin W, Xue Q, Jiang J, et al. Repositioning antipsychotic fluphenazine hydrochloride for treating triple negative breast cancer with brain metastases and lung metastases. Am J Cancer Res. 2019;9:459\u201378.","journal-title":"Am J Cancer Res"},{"key":"2992_CR34","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1158\/0008-5472.CAN-15-1233","volume":"76","author":"A Ranjan","year":"2016","unstructured":"Ranjan A, Gupta P, Srivastava SK. Penfluridol: an antipsychotic agent suppresses metastatic tumor growth in triple-negative breast cancer by inhibiting integrin signaling axis. Cancer Res. 2016;76:877\u201390.","journal-title":"Cancer Res"},{"key":"2992_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105295","volume":"163","author":"Y Xia","year":"2021","unstructured":"Xia Y, Xu F, Xiong M, Yang H, Lin W, Xie Y, et al. Repurposing of antipsychotic trifluoperazine for treating brain metastasis, lung metastasis and bone metastasis of melanoma by disrupting autophagy flux. Pharm Res. 2021;163:105295.","journal-title":"Pharm Res"},{"key":"2992_CR36","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"2992_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2024.153906","volume":"508","author":"W Chen","year":"2024","unstructured":"Chen W, Sun M, Sun Y, Yang Q, Gao H, Li L, et al. Proteasome inhibition induces apoptosis through simultaneous inactivation of MCL-1\/BCL-XL by NOXA independent of CHOP and JNK pathways. Toxicology. 2024;508:153906.","journal-title":"Toxicology"},{"key":"2992_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrm2308","volume":"9","author":"RJ Youle","year":"2008","unstructured":"Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008;9:47\u201359.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2992_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13045-022-01242-2","volume":"15","author":"M Wu","year":"2022","unstructured":"Wu M, Huang Q, Xie Y, Wu X, Ma H, Zhang Y, et al. Improvement of the anticancer efficacy of PD-1\/PD-L1 blockade via combination therapy and PD-L1 regulation. J Hematol Oncol. 2022;15:24.","journal-title":"J Hematol Oncol"},{"key":"2992_CR40","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1152\/physrev.00058.2021","volume":"103","author":"JS Harrington","year":"2023","unstructured":"Harrington JS, Ryter SW, Plataki M, Price DR, Choi AMK. Mitochondria in health, disease, and aging. Physiol Rev. 2023;103:2349\u2013422.","journal-title":"Physiol Rev"},{"key":"2992_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/15548627.2021.1888244","volume":"18","author":"P Tere\u0161ak","year":"2022","unstructured":"Tere\u0161ak P, Lapao A, Subic N, Boya P, Elazar Z, Simonsen A. Regulation of PRKN-independent mitophagy. Autophagy. 2022;18:24\u201339.","journal-title":"Autophagy"},{"key":"2992_CR42","doi-asserted-by":"publisher","first-page":"36372","DOI":"10.1074\/jbc.M113.509653","volume":"288","author":"K Okatsu","year":"2013","unstructured":"Okatsu K, Uno M, Koyano F, Go E, Kimura M, Oka T, et al. A dimeric PINK1-containing complex on depolarized mitochondria stimulates Parkin recruitment. J Biol Chem. 2013;288:36372\u201384.","journal-title":"J Biol Chem"},{"key":"2992_CR43","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41556-018-0176-2","volume":"20","author":"K Palikaras","year":"2018","unstructured":"Palikaras K, Lionaki E, Tavernarakis N. Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat Cell Biol. 2018;20:1013\u201322.","journal-title":"Nat Cell Biol"},{"key":"2992_CR44","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature14893","volume":"524","author":"M Lazarou","year":"2015","unstructured":"Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL, et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 2015;524:309\u201314.","journal-title":"Nature"},{"key":"2992_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13781-3","volume":"11","author":"N Moskal","year":"2020","unstructured":"Moskal N, Riccio V, Bashkurov M, Taddese R, Datti A, Lewis PN, et al. ROCK inhibitors upregulate the neuroprotective Parkin-mediated mitophagy pathway. Nat Commun. 2020;11:88.","journal-title":"Nat Commun"},{"key":"2992_CR46","doi-asserted-by":"crossref","unstructured":"Bernardini JP, Brouwer JM, Tan IK, Sandow JJ, Huang S, Stafford CA, et al. Parkin inhibits BAK and BAX apoptotic function by distinct mechanisms during mitophagy. Embo J. 2019;38:e99916.","DOI":"10.15252\/embj.201899916"},{"key":"2992_CR47","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.1016\/j.apsb.2021.06.007","volume":"11","author":"Y Tang","year":"2021","unstructured":"Tang Y, Wang L, Yi T, Xu J, Wang J, Qin JJ, et al. Synergistic effects of autophagy\/mitophagy inhibitors and magnolol promote apoptosis and antitumor efficacy. Acta Pharm Sin B. 2021;11:3966\u201382.","journal-title":"Acta Pharm Sin B"},{"key":"2992_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08335-6","volume":"10","author":"BS Padman","year":"2019","unstructured":"Padman BS, Nguyen TN, Uoselis L, Skulsuppaisarn M, Nguyen LK, Lazarou M. LC3\/GABARAPs drive ubiquitin-independent recruitment of Optineurin and NDP52 to amplify mitophagy. Nat Commun. 2019;10:408.","journal-title":"Nat Commun"},{"key":"2992_CR49","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1080\/15548627.2023.2214960","volume":"19","author":"S Giuliano","year":"2023","unstructured":"Giuliano S, Montemagno C, Domdom M-A, Teisseire M, Brest P, Klionsky DJ, et al. Should evidence of an autolysosomal de-acidification defect in Alzheimer and Parkinson diseases call for caution in prescribing chronic PPI and DMARD? Autophagy. 2023;19:2800\u20136.","journal-title":"Autophagy"},{"key":"2992_CR50","first-page":"34","volume":"10","author":"YQ Li","year":"2023","unstructured":"Li YQ, Sun FZ, Li CX, Mo HN, Zhou YT, Lv D, et al. RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer. Mil Med Res. 2023;10:34.","journal-title":"Mil Med Res"},{"key":"2992_CR51","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.trecan.2020.04.007","volume":"6","author":"J Fares","year":"2020","unstructured":"Fares J, Kanojia D, Rashidi A, Ulasov I, Lesniak MS. Genes that mediate metastasis across the blood-brain barrier. Trends Cancer. 2020;6:660\u201376.","journal-title":"Trends Cancer"},{"key":"2992_CR52","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-024-01808-1","volume":"9","author":"Y Xia","year":"2024","unstructured":"Xia Y, Sun M, Huang H, Jin WL. Drug repurposing for cancer therapy. Signal Transduct Target Ther. 2024;9:92.","journal-title":"Signal Transduct Target Ther"},{"key":"2992_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114403","volume":"184","author":"AJ Jhou","year":"2021","unstructured":"Jhou AJ, Chang HC, Hung CC, Lin HC, Lee YC, Liu WT, et al. Chlorpromazine, an antipsychotic agent, induces G2\/M phase arrest and apoptosis via regulation of the PI3K\/AKT\/mTOR-mediated autophagy pathways in human oral cancer. Biochem Pharm. 2021;184:114403.","journal-title":"Biochem Pharm"},{"key":"2992_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107420","volume":"209","author":"C Zhang","year":"2024","unstructured":"Zhang C, Lu X, Ni T, Wang Q, Gao X, Sun X, et al. Developing patient-derived organoids to demonstrate JX24120 inhibits SAMe synthesis in endometrial cancer by targeting MAT2B. Pharm Res. 2024;209:107420.","journal-title":"Pharm Res"},{"key":"2992_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7:27\u201331.","journal-title":"J Basic Clin Pharm"},{"key":"2992_CR56","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.tcb.2016.05.008","volume":"26","author":"TN Nguyen","year":"2016","unstructured":"Nguyen TN, Padman BS, Lazarou M. Deciphering the Molecular Signals of PINK1\/Parkin Mitophagy. Trends Cell Biol. 2016;26:733\u201344.","journal-title":"Trends Cell Biol"},{"key":"2992_CR57","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41420-024-02226-6","volume":"10","author":"C Chen","year":"2024","unstructured":"Chen C, Xiang A, Lin X, Guo J, Liu J, Hu S, et al. Mitophagy: insights into its signaling molecules, biological functions, and therapeutic potential in breast cancer. Cell Death Discov. 2024;10:457.","journal-title":"Cell Death Discov"},{"key":"2992_CR58","doi-asserted-by":"publisher","first-page":"7337","DOI":"10.7150\/thno.57804","volume":"11","author":"X Li","year":"2021","unstructured":"Li X, Wang M, Li S, Chen Y, Wang M, Wu Z, et al. HIF-1-induced mitochondrial ribosome protein L52: a mechanism for breast cancer cellular adaptation and metastatic initiation in response to hypoxia. Theranostics. 2021;11:7337\u201359.","journal-title":"Theranostics"},{"key":"2992_CR59","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41420-024-01914-7","volume":"10","author":"FD Naso","year":"2024","unstructured":"Naso FD, Bruqi K, Manzini V, Chiurchi\u00f9 V, D\u2019Onofrio M, Arisi I, et al. miR-218-5p and doxorubicin combination enhances anticancer activity in breast cancer cells through Parkin-dependent mitophagy inhibition. Cell Death Discov. 2024;10:149.","journal-title":"Cell Death Discov"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-02992-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-02992-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-02992-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T17:02:09Z","timestamp":1748451729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-02992-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,6,18]]}},"alternative-id":["2992"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-02992-9","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All mouse experiments conducted in this study were approved by the Institutional Animal Care and Use Committee of West China Hospital, Sichuan University (No. 2021862\u2009A). All methods were performed in accordance with the relevant guidelines and regulations.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}